{"title":"Evaluation of Silibinin Effect on U-CH2 and MCF-7 Cell Lines through xCELLigence System.","authors":"Zohreh Jahanafrooz, Beate Rinner","doi":"10.34172/apb.2023.002","DOIUrl":null,"url":null,"abstract":"Silibinin is an herbal polyphenol with high antioxidant and anticancer properties. In this study, its influence on U-CH2 (human sacral chordoma cell line) and MCF-7 (human breast adenocarcinoma cell line) cells was investigated and compared. We analyzed real-time cell viability by xCELLigence system. It was found that the cytotoxic effect of silibinin began about 10 hours after administration. Silibinin differentially influenced MCF-7 and U-CH2 cells and caused decrease in the cell index value of MCF-7 cells more than U-CH2 cells (more than 2 times) at 24 h. This suggests that silibinin is a promising drug for breast cancer but less favorable for chordoma.","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"13 1","pages":"5-6"},"PeriodicalIF":3.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871278/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced pharmaceutical bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/apb.2023.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Silibinin is an herbal polyphenol with high antioxidant and anticancer properties. In this study, its influence on U-CH2 (human sacral chordoma cell line) and MCF-7 (human breast adenocarcinoma cell line) cells was investigated and compared. We analyzed real-time cell viability by xCELLigence system. It was found that the cytotoxic effect of silibinin began about 10 hours after administration. Silibinin differentially influenced MCF-7 and U-CH2 cells and caused decrease in the cell index value of MCF-7 cells more than U-CH2 cells (more than 2 times) at 24 h. This suggests that silibinin is a promising drug for breast cancer but less favorable for chordoma.